PALISADE CAPITAL MANAGEMENT, LP - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773HAB8. A total of 17 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$1,665,000
-22.7%
1,000,0000.0%0.04%
-32.8%
Q3 2020$2,155,000
-85.6%
1,000,000
-66.7%
0.06%
-86.6%
Q2 2020$15,012,000
+239.1%
3,000,0000.0%0.48%
+205.8%
Q1 2020$4,427,0003,000,0000.16%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2020
NameSharesValueWeighting ↓
CVI Holdings, LLC 2,000,000$2,984,00010.48%
Context Capital Management, LLC 7,750,000$11,050,0006.27%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 4,750,000$9,690,0001.04%
TFG Asset Management GP Ltd 1,500,000$2,230,0000.39%
DeepCurrents Investment Group LLC 4,000,000$5,947,0000.29%
AQR Arbitrage LLC 5,000,000$7,484,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 3,000,000$4,427,0000.16%
Soros Fund Management 2,000,000$2,963,0000.15%
CSS LLC/IL 1,000,000$1,470,0000.12%
Verition Fund Management LLC 1,873,000$2,804,0000.11%
View complete list of INOVIO PHARMACEUTICALS INC shareholders